Printer Friendly

EMPI SALES, NET INCOME SET RECORDS FOR 1992 FOURTH QUARTER AND FULL YEAR

 ST. PAUL, Minn., Feb. 18 /PRNewswire/ -- Empi, Inc. (NASDAQ-NMS: EMPI), a medical device manufacturer, today announced record gains in sales and net income for the fourth quarter and full year 1992.
 For the year ended Dec. 31, 1992, net sales increased from $21.8 million to $33.4 million, a 53 percent increase. Net income for the year doubled, to $4.0 million from $2.0 million, and 1992 earnings per share rose to $.96 from $.59 per share in 1991.
 For the 1992 fourth quarter, sales rose 82 percent to $11.8 million, compared with $6.5 million during the final quarter of 1991. Fourth- quarter net income increased to $1.5 million from $784,000 in the year- earlier period, with per share earnings up 70 percent to $.34 from $.20.
 The fourth quarter of 1992 marked the 12th consecutive quarter during which Empi's revenue and earnings growth have exceeded 23 percent and 50 percent, respectively, over the prior year period.
 Donald D. Maurer, Empi president and chief executive officer, said: "The year 1992 was marked by several accomplishments which we believe will prove to be of major significance for our shareholders. In addition to launching our two newest proprietary products -- the INNOVA(TM) Feminine Incontinence Treatment System and the DUPEL(TM) iontophoresis drug delivery system -- we completed the acquisition of Medtronic Inc.'s Nortech division.
 "Fourth quarter revenue gains resulted from: continued core business expansion; sales of INNOVA, DUPEL and our Ultraflex(TM) line of dynamic splints; as well as sales from the Nortech acquisition completed in mid- November. Adherence to our long-term growth strategy -- whose elements are building the profitability of our core business, leveraging our sales force with new products and diversifying into new medical markets -- continues to produce good results for Empi."
 During 1992, Empi continued to diversify its revenue mix, with sales of new products reaching 21 percent of total sales, exceeding the company's goal.
 Maurer continued: "As we move into 1993, we are pleased with our integration of the Nortech acquisition and believe this transaction is an excellent fit for Empi, both for the added core business it brings and the expanded sales force for Empi's new product lines."
 Empi develops, manufactures and distributes non-invasive biomedical devices and accessories for electro-therapeutic applications in physical medicine, orthopedic, rehabilitation and neurology markets. The company's shares are traded on the NASDAQ National Market System under the symbol EMPI.
 EMPI, INC.
 CONDENSED STATEMENTS OF OPERATIONS
 (in thousands, except earnings per share)
 Three Months Ended Pct. 12 Months Ended Pct.
 12/31/92 12/31/91 Chg. 12/31/92 12/31/91 Chg.
 Net sales $11,765 $6,476 82 $33,355 $21,819 53
 Cost of sales
 and expenses 9,377 5,202 80 26,718 18,565 44
 Income before
 income taxes 2,388 1,274 87 6,637 3,254 104
 Income taxes 931 490 -- 2,588 1,213 --
 Net income $1,457 $784 86 $4,049 $2,041 98
 Net income per
 common share $.34 $.20 70 $.96 $.59 63
 Weighted average
 shares
 outstanding 4,234 4,008 -- 4,219 3,465 --
 -0- 2/18/93
 /CONTACT: Timothy Briggs of Empi, 612-639-2330; or Diane Rose of Padilla Speer Beardsley, 612-871-8877, for Empi/
 (EMPI)


CO: Empi, Inc. ST: Minnesota IN: MTC SU: ERN

KH -- MN005 -- 7897 02/18/93 12:24 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 18, 1993
Words:559
Previous Article:TORO REPORTS PROFITABLE SECOND QUARTER ON LOWER SALES
Next Article:MICHAEL FOODS REPORTS 1992 RESULTS
Topics:


Related Articles
EMPI ANNOUNCES STRONG GAINS IN SECOND-QUARTER SALES, EARNINGS
EMPI REPORTS STRONG GROWTH IN THIRD-QUARTER SALES, NET INCOME
EMPI REPORTS STRONG FIRST-QUARTER SALES AND EARNINGS GAINS
EMPI REPORTS RECORD RESULTS FOR SECOND QUARTER AND FIRST HALF
EMPI REPORTS STRONG SALES AND EARNINGS GAINS FOR 1993 THIRD QUARTER
EMPI ANNOUNCES RECORD SALES AND NET INCOME FOR 1993 FOURTH QUARTER AND FULL YEAR
EMPI ANNOUNCES FINANCIAL RESULTS FOR 1994 FOURTH QUARTER AND FULL YEAR
EMPI ANNOUNCES HIGHER FIRST-QUARTER SALES, EARNINGS
EMPI ANNOUNCES IMPROVED RESULTS FOR SECOND QUARTER AND FIRST HALF
EMPI ANNOUNCES FINANCIAL RESULTS FOR 1995 FOURTH QUARTER AND FULL YEAR

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters